Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $4.75 is 200.25% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 5.0753||$ 6.28|
|Low:||$ 4.65||$ 1.582|
Company Description (as filed with the SEC)
Ohr Pharmaceutical, Inc. ("we," "us," "our," "Ohr," or the "Company") is a pharmaceutical company which has been focused on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Recent Developments On January 2, 2019, the Company, Ohr Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Ohr ("Merger Sub"), and NeuBase Therapeutics, Inc., a Delaware corporation ("NeuBase"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into NeuBase, with NeuBase becoming a wholly-owned subsidiary of the Company and the surviving corporation of the merger (the "Merger"). ... More ...
Nasdaq Official Price
Aug. 16, 2019
Aug. 16, 2019